Towa Pharmaceutical Co (JP:4553) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Towa Pharmaceutical Co. has released a supplementary material for their Q1 financial results, detailing the inclusion of new subsidiaries in their consolidated balance sheets and statements of income for the fiscal year ending March 31, 2025. The report specifies that KAMATA and Kyushu Iyaku became consolidated subsidiaries in early 2024, while Sun Freres Lab was established in April 2024. Additionally, the company has revised its full-year earnings forecast.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.